OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
12 hedge funds and large institutions have $665K invested in OncoSec Medical Incorporated in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 8 closing their positions.
151% more capital invested
Capital invested by funds: $265K → $665K (+$400K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
29% less funds holding
Funds holding: 17 → 12 (-5)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$210K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$114K |
| 3 |
LPL Financial
San Diego,
California
|
+$34.5K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$3.82K |
| 5 |
BlackRock
New York
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$41K |
| 2 |
Two Sigma Investments
New York
|
-$35.5K |
| 3 |
VF
Virtu Financial
New York
|
-$22K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$20.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$13.9K |
ONCS Hedge Fund Activity: Q1 2023 in Review
12 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2023, worth a combined $665K — up 151% from $265K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ONCS and 3 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $210K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $41K sold.
- 12 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2023, down from 17 in Q4 2022.
- Funds reported $665K of OncoSec Medical Incorporated stock for Q1 2023, up 151% quarter-over-quarter.
- 3 funds opened new OncoSec Medical Incorporated positions in Q1 2023 and 8 closed out, a net change of -5 holders.
- The largest OncoSec Medical Incorporated buyer in Q1 2023 was FNY Investment Advisers, an estimated $210K added.
- The largest OncoSec Medical Incorporated seller in Q1 2023 was Renaissance Technologies, an estimated $41K sold.
Based on aggregated 13F filings for Q1 2023.